Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/54476
Title: Budgetary impact of diagnostic tests for visceral leishmaniasis in Brazil
Other Titles: Impacto orçamentário dos testes diagnósticos para leishmaniose visceral no Brasil
Impacto presupuestario de las pruebas diagnósticas para la leishmaniosis visceral en Brasil
Authors: Assis, Talia Santana Machado de
Silva, André Luís Ferreira de Azeredo da
Oliveira, Diana
Cota, Gláucia Fernandes
Werneck, Guilherme Loureiro
Rabello, Ana Lucia Teles
Affilliation: Centro Federal de Educação Tecnológica de Minas Gerais. Contagem, MG, Brasil/Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.
Instituto para Avaliação de Tecnologias em Saúde. Porto Alegre, RS. Brasil/Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil.
Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.
Universidade do Estado do Rio de Janeiro. Instituto de Medicina Social. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto René Rachou. Belo Horizonte, MG, Brasil.
Abstract: The aim of the present study was to estimate the financial costs of the incorporation and/or replacement of diagnostic tests for human visceral leishmaniasis (VL) in Brazil. The analysis was conducted from the perspective of the Brazilian Unified National Health System (SUS) over a period of three years. Six diagnostic tests were evaluated: the indirect immunofluorescence antibody test (IFAT), the IT LEISH rapid test, the parasitological examination of bone marrow aspirate, the direct agglutination test (DAT-LPC) standardized in the Clinical Research Laboratory, René Rachou Institute of the Oswaldo Cruz Foundation, the Kalazar Detect rapid test, and polymerase chain reaction (PCR). The assumptions used were the number of suspected cases of VL reported to the Brazilian Ministry of Health in 2014 and the direct cost of diagnostic tests. The costs to diagnose suspected cases of VL over three years using the IFAT and the DAT-LPC were estimated at USD 280,979.91 and USD 121,371.48, respectively. The analysis indicated that compared with the use of the IFAT, the incorporation of the DAT-LPC into the SUS would result in savings of USD 159,608.43. With regard to the budgetary impact of rapid tests, the use of IT LEISH resulted in savings of USD 21.708,72 over three years. Compared with a parasitological examination, diagnosis using PCR resulted in savings of USD 3,125,068.92 over three years. In this study, the replacement of the IFAT with the DAT-LPC proved financially advantageous. In addition, the replacement of the Kalazar Detect rapid test with the IT LEISH in 2015 was economically valuable, and the replacement of parasitological examination with PCR was indicated.
Keywords: Budgetary Control
Visceral Leishmaniasis
Diagnosis
Issue Date: 2017
Publisher: Escola Nacional de Saúde Pública
Citation: ASSIS, Tália Santana Machado de et al. Budgetary impact of diagnostic tests for visceral leishmaniasis in Brazil. Cad. Saúde Pública, v. 33 n. 12, e00142416, 2017. doi.org/10.1590/0102-311X00142416
DOI: 10.1590/0102-311X00142416
ISSN: 0102-311X
Copyright: open access
Appears in Collections:MG - IRR - Artigos de Periódicos
Files in This Item:
File Description SizeFormat 
budgetray impact.pdf6.43 MBAdobe PDFView/Open



FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.